Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
200
$10.26
$2.05K
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
42,177
$9.75
$411.31K
Phillip Pang
7 Jun 2023
Chief Medical Officer
Sold after exercise
5,000
$25.95
$129.73K
Phillip Pang
24 Jan 2023
Chief Medical Officer
Sold after exercise
30,000
$30.00
$900.06K
Phillip Pang
20 Jul 2022
Chief Medical Officer
Sold after exercise
5,000
$30.00
$150.00K
Saira Ramasastry
11 Jul 2022
Director
Sold after exercise
5,000
$30.00
$150.00K
Showing 250 of 462 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 435
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 76
Sales on a Rule 10b5-1 plan 84
Sales straight out of an exercise 130
Sales at will 217
Transactions with no price 0
Shares from compensation/vesting 178,543,571
Sales filed before the plan box existed 178
History held since 10 Oct 2019